145 related articles for article (PubMed ID: 9454888)
1. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
Kasper HU; Schneider-Stock R; Mellin W; Roessner A
Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
[TBL] [Abstract][Full Text] [Related]
2. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
[TBL] [Abstract][Full Text] [Related]
3. ras Gene mutations and expression of Ras signal transduction mediators in gastric adenocarcinomas.
Yoo J; Park SY; Robinson RA; Kang SJ; Ahn WS; Kang CS
Arch Pathol Lab Med; 2002 Sep; 126(9):1096-100. PubMed ID: 12204060
[TBL] [Abstract][Full Text] [Related]
4. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach.
van Rees BP; Musler A; Caspers E; Drillenburg P; Craanen ME; Polkowski W; Chibowski D; Offerhaus GJ
Hepatogastroenterology; 1999; 46(27):2063-8. PubMed ID: 10430398
[TBL] [Abstract][Full Text] [Related]
6. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
8. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
9. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum.
Garrett AP; Ng SW; Muto MG; Welch WR; Bell DA; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Apr; 77(1):105-11. PubMed ID: 10739698
[TBL] [Abstract][Full Text] [Related]
10. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.
Kimura K; Nagasaka T; Hoshizima N; Sasamoto H; Notohara K; Takeda M; Kominami K; Iishii T; Tanaka N; Matsubara N
J Int Med Res; 2007; 35(4):450-7. PubMed ID: 17697521
[TBL] [Abstract][Full Text] [Related]
11. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
[TBL] [Abstract][Full Text] [Related]
12. The role of ras gene mutation in gastric cancer and precancerous lesions.
Hao Y; Zhang J; Lu Y; Yi C; Qian W; Cui J
J Tongji Med Univ; 1998; 18(3):141-4. PubMed ID: 10806811
[TBL] [Abstract][Full Text] [Related]
13. K-ras exon 2 point mutations in human endometrial cancer.
Semczuk A; Schneider-Stock R; Berbec H; Marzec B; Jakowicki JA; Roessner A
Cancer Lett; 2001 Mar; 164(2):207-12. PubMed ID: 11179836
[TBL] [Abstract][Full Text] [Related]
14. p21 expression and mutation in gastric carcinoma: analysis by immunohistochemistry and PCR-SSCP.
Park YE; Choi KC; Choi YH
J Korean Med Sci; 1998 Oct; 13(5):507-12. PubMed ID: 9811180
[TBL] [Abstract][Full Text] [Related]
15. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers.
Fujita K; Ohuchi N; Yao T; Okumura M; Fukushima Y; Kanakura Y; Kitamura Y; Fujita J
Gastroenterology; 1987 Dec; 93(6):1339-45. PubMed ID: 3315826
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of ras proto-oncogene mutations in selected mammalian tumors.
Watzinger F; Mayr B; Gamerith R; Vetter C; Lion T
Mol Carcinog; 2001 Apr; 30(4):190-8. PubMed ID: 11346881
[TBL] [Abstract][Full Text] [Related]
17. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
Cui Q; Wang Z; Chen J; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
[TBL] [Abstract][Full Text] [Related]
18. Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells.
Song JJ; Lee H; Kim E; Kim YS; Yoo NC; Roh JK; Kim BS; Kim J
Cancer Lett; 2000 Aug; 157(1):1-7. PubMed ID: 10893435
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.
Nemunaitis J; Klemow S; Tong A; Courtney A; Johnston W; Mack M; Taylor W; Solano M; Stone M; Mallams J; Mues G
Am J Clin Oncol; 1998 Apr; 21(2):155-60. PubMed ID: 9537203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]